Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Ra Capital Nexus Fund Iv, L.p.
Over the trailing 90 days, Ra Capital Nexus Fund Iv, L.p. (Director at Hemab Therapeutics Holdings, Inc.) bought $52.2M of stock in COAG, per 15 SEC Form 4 transactions.
- Role
- Director
- Companies
- COAG
- Window
- Trailing 90 days · 15 transactions · CIK 2053586
- Net activity
- +$52.2M ($52.2M bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, Inc. | 15 | $52.2M | — | $52.2M |
Transactions (15)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-06 | COAG | Buy | 14.6K | $347K | Open market or private purchase |
| 2026-05-06 | COAG | Buy | 53.4K | $1.3M | Open market or private purchase |
| 2026-05-05 | COAG | Buy | 10.3K | $257K | Open market or private purchase |
| 2026-05-05 | COAG | Buy | 87.1K | $2.1M | Open market or private purchase |
| 2026-05-04 | COAG | Buy | 2.5M | $45.7M | Open market or private purchase |
| 2026-05-04 | COAG | Sell | 10.1K | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Buy | 133.8K | $2.4M | Open market or private purchase |
| 2026-05-04 | COAG | Sell | 57.0K | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Buy | 221.2K | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Buy | 1.0M | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Sell | 27.7K | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Buy | 3.6M | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Sell | 42.3K | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Sell | 18.1K | $0 | Conversion of derivative security |
| 2026-05-04 | COAG | Sell | 64.7K | $0 | Conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Ra's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.